Section Arrow
PHAR.NASDAQ
- Pharming Group NV
Quotes are at least 15-min delayed:2026/04/09 05:22 EDT
Pre Market
Last
 --
-- (--)
Bid
16.58
Ask
16.9
High -- 
Low -- 
Volume -- 
Regular Hours (Closed)
Last
 16.98
+0.56 (+3.41%)
Day High 
17.38 
Prev. Close
16.42 
1-M High
17.32 
Volume 
25.29K 
Bid
16.58
Ask
16.9
Day Low
16.46 
Open
17.34 
1-M Low
14.5 
Market Cap 
1.14B 
Currency 美元 
P/E 410.5 
%Yield -- 
10-SMA 16.39 
20-SMA 15.96 
50-SMA 16.57 
52-W High 21.34 
52-W Low
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
0.04/0.27
Enterprise Value
1.25B
Balance Sheet
Book Value Per Share
3.92
Cash Flow
Cash Flow Yield
0.04
Income Statement
Total Revenue
376.13M
Operating Revenue Per Share
3.14
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
QNCXQuince Therapeutics0.1831+0.0201+12.33%-- 
Pre Market 0.1642 -0.0189 -10.32%
VRAXVirax Biolabs Group Limited0.15+0.01+7.14%-- 
Pre Market 0.142 -0.008 -5.33%
ELABPmgc Holdings Inc4.5+1.05+30.43%0PE
Pre Market 4.47 -0.03 -0.67%
CUECue Biopharma0.2738+0.0856+45.48%-- 
Pre Market 0.2299 -0.0439 -16.03%
GERNGeron Corp1.71-0.03-1.72%-- 
Pre Market 1.7 -0.01 -0.58%
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Pharming Group is a biotechnology company focused on developing and commercializing therapies for rare and ultra-rare diseases, particularly immunological and genetic conditions with high unmet need. It operates as an integrated company with capabilities across clinical development, manufacturing, regulatory affairs, and commercialization, supported by scientific and operational expertise. It leverages its efficient infrastructure to expand its pipeline and improve patient access to treatment. The Company operates in the United States, Europe, and the rest of the world, with the United States contributing the majority of its revenue.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.